Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Therapeutic Targeting of Toll-Like Receptors: A Review of Toll-Like Receptors and Their Signaling Pathways in Psoriasis Publisher Pubmed



Rahmani F1, 2 ; Rezaei N1, 3, 4
Authors

Source: Expert Review of Clinical Immunology Published:2016


Abstract

Introduction: Expression of various Toll-like receptors (TLR) in keratinocytes (KCs) has offered new insights into the pathogenesis of psoriasis. When plasmacytoid dendritic cells (pDCs) are scarce in established psoriatic lesions, KCs take the responsibility to secrete IFN type 1 through TLR9 activation. Antagonists of TLR7 and TLR8 and anti-IL-12/IL-23 substances have shown promising results in treating psoriasis. Areas covered: References in this study were extracted from Scopus, PubMed and Embase databases by the search term: (‘Toll-Like Receptors’ OR ‘TLR’) AND (‘Psoriasis’ OR ‘Arthritis, Psoriatic’ OR ‘PsA’). Expert commentary: As the prevailing cell type, KCs play a major role in the maintenance of psoriatic lesions. By specific upregulation of IL-36 R, KCs can start the IL-23/IL-12 axis, leading to production of major culprits of psoriatic phenotype IL-17 and IL-22. Targeting IL-36 R could be considered as a new therapeutic target to eliminate cutaneous manifestations of psoriasis. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
7. Anesthetic Considerations in a Patient With Psoriasis Undergoing Cabg Surgery, Journal of Cellular and Molecular Anesthesia (2019)
10. Unfulfilled Inflammatory Resolution: A Key Factor in the Pathogenesis of Psoriasis, Iranian Journal of Allergy# Asthma and Immunology (2020)
12. Toll-Like Receptors As Targets for Allergen Immunotherapy, Current Opinion in Allergy and Clinical Immunology (2015)
14. Cytokine Alterations in Psoriasis: An Updated Review, Expert Review of Clinical Immunology (2021)
16. Therapeutic Targeting of Toll-Like Receptors in Cutaneous Disorders, Expert Opinion on Therapeutic Targets (2015)
17. The Potential Role of Th17 Lymphocytes in Patients With Psoriasis, Anais Brasileiros de Dermatologia (2018)